{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:08:24Z","timestamp":1783098504097,"version":"3.54.6"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Health Popul Nutr"],"DOI":"10.1186\/s41043-025-01202-9","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T11:05:30Z","timestamp":1766747130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Initial different human papillomavirus infection statuses and subsequent infection risk: a decade-long longitudinal study"],"prefix":"10.1186","volume":"45","author":[{"given":"Han","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingfen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"1202_CR1","first-page":"26","volume":"7","author":"L Bruni","year":"2019","unstructured":"Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, G\u00f3mez D, Mu\u00f1oz J, Bosch F, De Sanjos\u00e9 S. Human papillomavirus and related diseases report. ICO\/IARC Inform Centre HPV Cancer (HPV Inform Centre). 2019;7:26\u201342.","journal-title":"ICO\/IARC Inform Centre HPV Cancer (HPV Inform Centre)"},{"issue":"2","key":"1202_CR2","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn M, Weiderpass E, Bruni L, de Sanjos\u00e9 S, Saraiya M, Ferlay J, Bray F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191\u2013203.","journal-title":"Lancet Glob Health"},{"issue":"5","key":"1202_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342\u201350.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"1202_CR4","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.drudis.2019.07.011","volume":"24","author":"AM Almeida","year":"2019","unstructured":"Almeida AM, Queiroz JA, Sousa F, Sousa \u00c2. Cervical cancer and HPV infection: ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins. Drug Discov Today. 2019;24(10):2044\u201357.","journal-title":"Drug Discov Today"},{"key":"1202_CR5","doi-asserted-by":"crossref","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-386.","DOI":"10.1002\/ijc.29210"},{"issue":"Suppl 5","key":"1202_CR6","doi-asserted-by":"publisher","first-page":"F71","DOI":"10.1016\/j.vaccine.2012.05.091","volume":"30","author":"PL Stern","year":"2012","unstructured":"Stern PL, van der Burg SH, Hampson IN, Broker TR, Fiander A, Lacey CJ, Kitchener HC, Einstein MH. Therapy of human papillomavirus-related disease. Vaccine. 2012;30(Suppl 5):F71\u201382.","journal-title":"Vaccine"},{"issue":"6","key":"1202_CR7","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Mu\u00f1oz","year":"2003","unstructured":"Mu\u00f1oz N, Bosch FX, de Sanjos\u00e9 S, Herrero R, Castellsagu\u00e9 X, Shah KV, Snijders PJ, Meijer CJ. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518\u201327.","journal-title":"N Engl J Med"},{"issue":"7","key":"1202_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1634\/theoncologist.10-7-528","volume":"10","author":"A Mahdavi","year":"2005","unstructured":"Mahdavi A, Monk BJ. Vaccines against human papillomavirus and cervical cancer: promises and challenges. Oncologist. 2005;10(7):528\u201338.","journal-title":"Oncologist"},{"issue":"1","key":"1202_CR9","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12985-025-02904-6","volume":"22","author":"Y Jing","year":"2025","unstructured":"Jing Y, Chen J, Lin F, Huang X, Liu Y, Zhao M, Ye C, Zhao L, Liu X, Yang J. Multiple high-risk human papillomavirus infections exacerbate cervical lesion risk: epidemiological evidence from suining, Sichuan. Virol J. 2025;22(1):268.","journal-title":"Virol J"},{"key":"1202_CR10","first-page":"101243","volume":"51","author":"J Zeitouni","year":"2025","unstructured":"Zeitouni J, Osazuwa-Peters N, Dundar Y, Zimet G, Varvares MA. Two decades of the HPV vaccine: its promise, progress, prospects, projections, and posterity. Lancet Reg Health Am. 2025;51:101243.","journal-title":"Lancet Reg Health Am"},{"key":"1202_CR11","doi-asserted-by":"publisher","unstructured":"Wang J, Song L. China's Integration of HPV Vaccine into National Immunization Program: Current Challenges and Future Path. J Cancer Educ. 2025 Oct 23. Epub ahead of print. PMID: 41129077. https:\/\/doi.org\/10.1007\/s13187-025-02758-0}","DOI":"10.1007\/s13187-025-02758-0"},{"key":"1202_CR12","doi-asserted-by":"publisher","first-page":"127800","DOI":"10.1016\/j.vaccine.2025.127800","volume":"65","author":"N Shi","year":"2025","unstructured":"Shi N, Xiu S, Wang J, Shen Y, Jin H. Subjective norms and perceived behavior control are more critical than attitudes in HPV vaccination: an investigation in China. Vaccine. 2025;65:127800.","journal-title":"Vaccine"},{"key":"1202_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12010075","author":"Z Lin","year":"2024","unstructured":"Lin Z, Liang X, Su L, Peng W, Chen H, Fang Y, et al. Coverage with the first dose of human papillomavirus vaccination among females aged 9\u201350 years in Shenzhen, China: a surveillance based on administrative health records in 2023. Vaccines (Basel). 2024. https:\/\/doi.org\/10.3390\/vaccines12010075.","journal-title":"Vaccines (Basel)"},{"key":"1202_CR14","unstructured":"International Agency for Research on Cancer W. Cervical cancer estimated incidence, mortality and prevalence worldwide in 2012. World Health Organization; 2012."},{"key":"1202_CR15","volume-title":"World cancer report 2014","author":"CP Wild","year":"2014","unstructured":"Wild CP, Stewart BW, Wild C. World cancer report 2014. Switzerland: World Health Organization Geneva; 2014."},{"issue":"1","key":"1202_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1037\/1082-989X.6.1.18","volume":"6","author":"DS Nagin","year":"2001","unstructured":"Nagin DS, Tremblay RE. Analyzing developmental trajectories of distinct but related behaviors: a group-based method. Psychol Methods. 2001;6(1):18\u201334.","journal-title":"Psychol Methods"},{"issue":"2\u20133","key":"1202_CR17","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000360229","volume":"65","author":"DS Nagin","year":"2014","unstructured":"Nagin DS. Group-based trajectory modeling: an overview. Ann Nutr Metab. 2014;65(2\u20133):205\u201310.","journal-title":"Ann Nutr Metab"},{"issue":"4","key":"1202_CR18","doi-asserted-by":"publisher","first-page":"e29608","DOI":"10.1002\/jmv.29608","volume":"96","author":"A Trevisan","year":"2024","unstructured":"Trevisan A, Candeias JMG, Thomann P, Villa LL, Franco EL, Trottier H. Naturally developed HPV16 antibodies and risk of newly detected cervical HPV infection outcomes. J Med Virol. 2024;96(4):e29608.","journal-title":"J Med Virol"},{"key":"1202_CR19","doi-asserted-by":"publisher","first-page":"1612761","DOI":"10.3389\/fimmu.2025.1612761","volume":"16","author":"R Ewaisha","year":"2025","unstructured":"Ewaisha R, Ruffin MT, Williams S, Chung Y, DeGraffinreid CR, Paskett ED, Reiter PL, Qiu J, Brenner DE, Anderson KS. Serum profiling of the antibody response to HPV in women with or without abnormal cervical cytology undergoing cervical cancer screening. Front Immunol. 2025;16:1612761.","journal-title":"Front Immunol"},{"issue":"8","key":"1202_CR20","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1093\/infdis\/jis494","volume":"206","author":"DP Durham","year":"2012","unstructured":"Durham DP, Poolman EM, Ibuka Y, Townsend JP, Galvani AP. Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types. J Infect Dis. 2012;206(8):1291\u20138.","journal-title":"J Infect Dis"},{"key":"1202_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.virusres.2016.11.023","volume":"231","author":"JA Westrich","year":"2017","unstructured":"Westrich JA, Warren CJ, Pyeon D. Evasion of host immune defenses by human papillomavirus. Virus Res. 2017;231:21\u201333.","journal-title":"Virus Res"},{"issue":"12","key":"1202_CR22","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1097\/OLQ.0000000000000201","volume":"41","author":"L Jing","year":"2014","unstructured":"Jing L, Zhong X, Zhong Z, Huang W, Liu Y, Yang G, et al. Prevalence of human papillomavirus infection in Guangdong Province, China: a population-based survey of 78,355 women. Sex Transm Dis. 2014;41(12):732\u20138.","journal-title":"Sex Transm Dis"},{"issue":"22","key":"1202_CR23","doi-asserted-by":"publisher","first-page":"11070","DOI":"10.1158\/0008-5472.CAN-06-2034","volume":"66","author":"AJ Garc\u00eda-Pi\u00f1eres","year":"2006","unstructured":"Garc\u00eda-Pi\u00f1eres AJ, Hildesheim A, Herrero R, Trivett M, Williams M, Atmetlla I, Ram\u00edrez M, Villegas M, Schiffman M, Rodr\u00edguez AC, et al. Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. Cancer Res. 2006;66(22):11070\u20136.","journal-title":"Cancer Res"},{"key":"1202_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/life15020153","author":"S Varesano","year":"2025","unstructured":"Varesano S, Ciccarese G, Paudice M, Mazzocco K, Gaggero G, Ferrero S, et al. Evaluating HPV viral load and multiple infections for enhanced cervical cancer risk-based assessment. Life. 2025. https:\/\/doi.org\/10.3390\/life15020153.","journal-title":"Life"},{"issue":"4","key":"1202_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/CEJ.0000000000000920","volume":"34","author":"I Akinyi","year":"2025","unstructured":"Akinyi I, Ouma OJ, Ogutu S, Ogola E, Owenga J, Ayodo G, Omondi D, Awandu SS, Vanden Broeck D, Redzic N, et al. HPV infection patterns and viral load distribution: implication on cervical cancer prevention in Western Kenya. Eur J Cancer Prev. 2025;34(4):329\u201336.","journal-title":"Eur J Cancer Prev"},{"issue":"6","key":"1202_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1093\/jnci\/92.6.464","volume":"92","author":"R Herrero","year":"2000","unstructured":"Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst. 2000;92(6):464\u201374.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"1202_CR27","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/jmv.24748","volume":"89","author":"D Cao","year":"2017","unstructured":"Cao D, Zhang S, Zhang Q, Wei X, Zhao M, Ma Q, Li Y, Wang L, Pei M, Yang T, et al. Prevalence of high-risk human papillomavirus infection among women in Shaanxi Province of china: A hospital-based investigation. J Med Virol. 2017;89(7):1281\u20136.","journal-title":"J Med Virol"},{"issue":"1","key":"1202_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s12905-023-02558-y","volume":"23","author":"G Tuerxun","year":"2023","unstructured":"Tuerxun G, Abudurexiti G, Abulizi G. Prevalence, persistence, clearance and risk factors for HPV infection in rural Uyghur women in China. BMC Womens Health. 2023;23(1):433.","journal-title":"BMC Womens Health"},{"key":"1202_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15222880","author":"S Baek","year":"2025","unstructured":"Baek S, Ludwig S, Sievers SL, Einzmann T, Zhao Y, Pilch H. Impact of single- versus multiple-type HPV infections on cervical cytological and histological abnormalities: the dominant oncogenic potential of HPV16 single-type infections. Diagnostics. 2025. https:\/\/doi.org\/10.3390\/diagnostics15222880.","journal-title":"Diagnostics"},{"issue":"11","key":"1202_CR30","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1086\/647993","volume":"200","author":"LF Xi","year":"2009","unstructured":"Xi LF, Hughes JP, Edelstein ZR, Kiviat NB, Koutsky LA, Mao C, et al. Human papillomavirus (HPV) type 16 and type 18 DNA loads at baseline and persistence of type-specific infection during a 2-year follow-up. J Infect Dis. 2009;200(11):1789\u201397.","journal-title":"J Infect Dis"},{"key":"1202_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7310894","volume":"2016","author":"DH Adler","year":"2016","unstructured":"Adler DH, Wallace M, Bennie T, Abar B, Meiring TL, Williamson AL, et al. Cumulative impact of HIV and multiple concurrent human papillomavirus infections on the risk of cervical dysplasia. Adv Virol. 2016;2016:7310894.","journal-title":"Adv Virol"},{"issue":"6","key":"1202_CR32","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/ijc.27828","volume":"133","author":"AF Rositch","year":"2013","unstructured":"Rositch AF, Koshiol J, Hudgens MG, Razzaghi H, Backes DM, Pimenta JM, Franco EL, Poole C, Smith JS. Patterns of persistent genital human papillomavirus infection among women worldwide: a literature review and meta-analysis. Int J Cancer. 2013;133(6):1271\u201385.","journal-title":"Int J Cancer"},{"issue":"7","key":"1202_CR33","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1097\/IGC.0b013e31829e9fb4","volume":"23","author":"EL Dickson","year":"2013","unstructured":"Dickson EL, Vogel RI, Bliss RL, Downs LS Jr. Multiple-type human papillomavirus (HPV) infections: a cross-sectional analysis of the prevalence of specific types in 309,000 women referred for HPV testing at the time of cervical cytology. Int J Gynecol Cancer. 2013;23(7):1295\u2013302.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"1202_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1086\/317638","volume":"183","author":"KL Liaw","year":"2001","unstructured":"Liaw KL, Hildesheim A, Burk RD, Gravitt P, Wacholder S, Manos MM, Scott DR, Sherman ME, Kurman RJ, Glass AG, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis. 2001;183(1):8\u201315.","journal-title":"J Infect Dis"},{"key":"1202_CR35","doi-asserted-by":"publisher","first-page":"127632","DOI":"10.1016\/j.vaccine.2025.127632","volume":"63","author":"P Kassam","year":"2025","unstructured":"Kassam P, Laurie C, El-Zein M, Tota JE, Tellier PP, Coutl\u00e9e F, Burchell AN, Franco EL. Impact of HPV vaccination on the incidence and clearance of HPV infections in sexually active young women. Vaccine. 2025;63:127632.","journal-title":"Vaccine"},{"key":"1202_CR36","doi-asserted-by":"crossref","unstructured":"Ussai S, Seyidov T, Khomasuridze T, On Behalf Of The Regional Alliance Group Of Experts On Hpv V. : Regional Alliance for Cervical Cancer Prevention in Eastern Europe and Central Asia: Progressing Towards the Target 1 of the Global Strategy for Cervical Cancer Elimination. Healthcare (Basel) 2025, 13(10).","DOI":"10.3390\/healthcare13101209"},{"key":"1202_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12101110","author":"KJ Min","year":"2024","unstructured":"Min KJ, Ouh YT, Bae S, Ji YB, Lee JK, Kim JW, et al. Position statement about gender-neutral HPV vaccination in Korea. Vaccines. 2024. https:\/\/doi.org\/10.3390\/vaccines12101110.","journal-title":"Vaccines"}],"container-title":["Journal of Health, Population and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41043-025-01202-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-025-01202-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-025-01202-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:03:51Z","timestamp":1769601831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41043-025-01202-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1202"],"URL":"https:\/\/doi.org\/10.1186\/s41043-025-01202-9","relation":{},"ISSN":["2072-1315"],"issn-type":[{"value":"2072-1315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical review of the Medical Ethics Committee of Wuxi Maternal and Child Health Hospital has approved all the data obtained from this retrospective study (Approval number: 2025-06-0126-01).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}